The International journal of risk & safety in medicine
-
Review
A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation.
Since the mid 1990's, Canada has introduced partial direct-to-consumer advertising (DTCA) of prescription drugs through administrative policy shifts. Little documentation exists on how regulation occurs in practice. ⋯ There is an astonishing degree of discordance between public health priorities and regulation of DTCA in Canada. The current approach to enforcement is notable both for its lack of teeth and lack of accountability and transparency.
-
Central Venous Catheterisation (CVC) has occasionally been associated with cases of retained guidewires in patients after surgery. In theory, this is a completely avoidable complication; however, as with any human procedure, operator error leading to guidewires being occasionally retained cannot be fully eliminated. ⋯ Further work to eliminate/engineer out the possibility of guidewires being retained is proposed.
-
Wrong site confusions are among the most common mistakes in operations of twosome organs. ⋯ This study illustrates the high error that can result in the absence of side marking prior to cataract surgery, as well as in operations on other twosome organs.
-
In 2010, the Affordable Care Act (ACA) was signed into law. The Act seeks to improve the access of Americans to improved quality health care, while controlling the nation's escalating health care expenditures. The Act is scheduled for further implementation in 2014. ⋯ The article qualified these findings by emphasizing that doctors must learn to advocate on behalf of their profession if the potential benefits of the ACA are to be realized.
-
There is an increasing use of herbal products and herbal medicines globally with the belief that herbal medicines are always 'safe' and carry no risk because they are from natural sources. However, there are concerns regarding medicinal plants and their ability to produce adverse effects. The growing herbal medicine usage has increased the need to monitor the safety of herbal medicines. Thus, the recommended approach by the World Health Organization (WHO) is to include herbal medicines in existing national pharmacovigilance systems. ⋯ These results showed inadequate adverse effects monitoring (Pharmacovigilance) amongst the practitioners and underscore the necessity to educate and enlighten herbal medicine practitioners on the need for pharmacovigilance activity of herbal products.